Mobile

The purpose of this study is to describe the pharmacokinetics of moxifloxacin in children to see what the best dose should be for children in the future. Pharmacokinetics is to see how the body absorb...

Mise à jour : Il y a 5 ans
Référence : EUCTR2012-000737-40

The purpose of this study is to describe the pharmacokinetics of moxifloxacin in children to see what the best dose should be for children in the future. Pharmacokinetics is to see how the body absorbs, distributes, breaks down and gets rid of the study drug

Femme et Homme

  • | Pays :
    • -
  • | Organes :
    • -
  • | Spécialités :
    • -

Extrait

The primary objective of this study is to describe the pharmacokinetics of moxifloxacin in children of different ages, in order to determine a dose which will provide a similar exposure as seen in adults treated with the approved therapeutic dose of 400 mg

Critère d'inclusion

  • No medical condition specified as the purpose of this study is to describe the pharmacokinetics of moxifloxacin in children for future antibiotic treatment

Liens